Literature DB >> 23615922

Inadequate methodology renders results on the use of tranexamic acid inconclusive.

Patrice Forget, Irina Grosu, Emmanuel Thienpont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615922      PMCID: PMC3685648          DOI: 10.1007/s00264-013-1889-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


× No keyword cloud information.
  4 in total

1.  Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee.

Authors:  N Tanaka; H Sakahashi; E Sato; K Hirose; T Ishima; S Ishii
Journal:  J Bone Joint Surg Br       Date:  2001-07

2.  Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.

Authors:  Rajesh N Maniar; Gaurav Kumar; Tushar Singhi; Ravi Mohan Nayak; Parul R Maniar
Journal:  Clin Orthop Relat Res       Date:  2012-03-15       Impact factor: 4.176

Review 3.  The effects of mild perioperative hypothermia on blood loss and transfusion requirement.

Authors:  Suman Rajagopalan; Edward Mascha; Jie Na; Daniel I Sessler
Journal:  Anesthesiology       Date:  2008-01       Impact factor: 7.892

4.  Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty.

Authors:  Takao Iwai; Shigeyoshi Tsuji; Tetsuya Tomita; Kazuomi Sugamoto; Yoshikawa Hideki; Masayuki Hamada
Journal:  Int Orthop       Date:  2013-02-01       Impact factor: 3.075

  4 in total
  2 in total

1.  Topical administration of tranexamic acid in hip arthroplasty.

Authors:  Joon Soon Kang; Kyoung Ho Moon; Bom Soo Kim; Seong Jo Yang
Journal:  Int Orthop       Date:  2016-04-18       Impact factor: 3.075

2.  The impact of mild peri-operative hypothermia on the effectiveness of tranexamic acid in total hip arthroplasty.

Authors:  Nicolas Reina; Peter Fennema; Hervé Hourlier
Journal:  Int Orthop       Date:  2016-03-23       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.